Inkjet printing of drug substances and use of porous substrates-towards individualized dosing.
about
Rapid interferometric imaging of printed drug laden multilayer structures3D Printing technologies for drug delivery: a review.Emergence of 3D Printed Dosage Forms: Opportunities and Challenges.Drop Printing of Pharmaceuticals: Effect of Molecular Weight on PEG Coated-Naproxen/PEG3350 Solid Dispersions.Drop-on-Demand System for Manufacturing of Melt-based Solid Oral Dosage: Effect of Critical Process Parameters on Product Quality.Recent advances in inkjet dispensing technologies: applications in drug discovery.Oromucosal film preparations: classification and characterization methods.Printing technologies in fabrication of drug delivery systems.3D-printing and the effect on medical costs: a new era?Current Trends on Medical and Pharmaceutical Applications of Inkjet Printing Technology.Visualization and Non-Destructive Quantification of Inkjet-Printed Pharmaceuticals on Different Substrates Using Raman Spectroscopy and Raman Chemical Imaging.Multifunctional substrates of thin porous alumina for cell biosensors.Application of three-dimensional printing for colon targeted drug delivery systems.Printing of small molecular medicines from the vapor phase.Personalised 3D Printed Medicines: Which Techniques and Polymers Are More Successful?Engineered Paper-Based Cell Culture Platforms.Tailored Approaches in Drug Development and Diagnostics: From Molecular Design to Biological Model Systems.Novel Biomaterials Used in Medical 3D Printing Techniques.Growth and modelling of spherical crystalline morphologies of molecular materials.Cellulose Nanopaper and Nanofoam for Patient-Tailored Drug Delivery
P2860
Q30443273-92C9DD69-4FD5-48C0-9C14-A5AAC1B7C87CQ34674609-4663F45A-4EE5-4240-A151-8335014A031DQ36021826-6812A3C3-6AF1-42E9-B644-2EB8117553ACQ36748666-D098ADB8-EAA8-42EF-94A6-574E3E7801A1Q37175006-A8CC8E98-DFA3-4715-B231-6F1F31549BF7Q38020878-D5D85797-6638-495E-B29B-71BA37AF8586Q38114516-88C33D70-557E-4FA1-B44F-67A3885162CFQ38164422-35408D04-E83D-4C6F-9C6C-8C02E84BFBC1Q38713898-A4E6EF06-3D9C-4EFC-8319-4D796D6B7EB9Q38833393-DEADF1FF-5DAC-484C-A87B-BCC994B43016Q38934368-B41379D1-053D-4704-B5C9-9A70F292EE93Q39244142-D13274F3-F621-4653-A23B-CF3601BD267AQ41358276-D79E8B79-AD23-4B68-AF77-497BF2361A44Q42365551-2CBA23E7-2560-44B0-8934-C51E0998DAA8Q47114623-ECCC2250-1FED-42D2-AB44-68B440C63435Q47405139-24664D84-6DBE-4F7B-84E1-5466171A0A30Q47690085-A3DC4A91-034A-456C-AA86-E0432F1A1986Q50133677-21E79B29-F0F6-4951-8777-EE12E92329F3Q53412744-809C310F-3219-469B-B8AD-7E371D4B0AC2Q58198984-D33FBB3A-520E-40D6-8230-D3AB3E69CA44
P2860
Inkjet printing of drug substances and use of porous substrates-towards individualized dosing.
description
2011 nî lūn-bûn
@nan
2011 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի մարտին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Inkjet printing of drug substa ...... towards individualized dosing.
@ast
Inkjet printing of drug substa ...... towards individualized dosing.
@en
Inkjet printing of drug substa ...... towards individualized dosing.
@nl
type
label
Inkjet printing of drug substa ...... towards individualized dosing.
@ast
Inkjet printing of drug substa ...... towards individualized dosing.
@en
Inkjet printing of drug substa ...... towards individualized dosing.
@nl
prefLabel
Inkjet printing of drug substa ...... towards individualized dosing.
@ast
Inkjet printing of drug substa ...... towards individualized dosing.
@en
Inkjet printing of drug substa ...... towards individualized dosing.
@nl
P2093
P356
P1476
Inkjet printing of drug substa ...... towards individualized dosing.
@en
P2093
Anni Määttänen
Axel Meierjohann
Jouko Peltonen
Leif Kronberg
Niklas Sandler
Petri Ihalainen
P304
P356
10.1002/JPS.22526
P407
P577
2011-03-01T00:00:00Z